BeStock  
Markets › Compare › NBTX vs NTLA

NBTX vs NTLA

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
NBTX · Nanobiotix$26.50 ▼ 2.98%
NTLA · Intellia Therapeutics$10.00 ▲ 5.04%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

81126171215260Nov 24, '25May 26, '26Nov 20, '26
  • NBTX +20.5%
  • NTLA +19.8%

Head to head

MetricNBTXNTLA
Price$26.50$10.00
Change today▼ 2.98%▲ 5.04%
Market cap$1.35B$1.40B
Return, 3 months-33.2%-20.4%
Return, year to date+14.6%+11.2%
Return, 1 year+26.6%+21.8%
P/E (TTM)––
P/B-36.92.3
P/E percentile vs own 5y11th78th
Dividend yield––
Revenue growth (YoY, latest qtr)+355.3%-48.0%
Net profit growth (YoY)+64.8%-25.8%
Gross margin––
Operating margin-353.6%-821.2%
Net margin-632.5%-805.7%
Return on equity–-62.6%
Analyst target vs. price+141.5%+92.0%
Analyst buy share100%36%
RSI (14)4041
30-day volatility91.5%77.8%
Max drawdown, 1 year-61.7%-46.6%
Trend readStrong downtrendStrong downtrend
Analyst consensusBuyHold

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • NTLA is the largest of the group by market value.
  • NBTX has returned the most over the past year.
  • NBTX is growing revenue fastest.
  • NBTX keeps the most profit per dollar of sales.
  • NTLA has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top